DETECT: Target Volume for Rectal Endoluminal Radiation Boosting
DETECT: Defining the Target Volume for Endoluminal Radiation Boosting in Patients With Rectal Cancer
Maastricht Radiation Oncology
50 participants
Aug 16, 2022
OBSERVATIONAL
Conditions
Summary
The aim of the study is to provide prospective data regarding microscopic tumor spread in all directions from the macroscopic tumor in pathology specimens, as seen by eye, and on imaging to define the target volume for endoluminal radiation boosting in rectal cancer patients.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
3D endorectal ultrasound.
Rigid rectoscopy.
For some patients, images of the resection specimen (note: NOT of the patients) during the pathological process will be acquired.
Locations(3)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04927897